Federal Register / Vol. 70, No. 216 / Wednesday, November 9, 2005 / Notices 68069

By order of the Board of Governors of the 

Federal Reserve System, November 2, 2005. 

Jennifer J. Johnson, 

Secretary of the Board.

[FR Doc. 05–22224 Filed 11–8–05; 8:45 am]

BILLING CODE 6210–01–C

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Toxicology Program (NTP); 

Liaison and Scientific Review Office; 

Meeting of the Scientific Advisory 

Committee on Alternative 

Toxicological Methods (SACATM)

AGENCY: National Institute of 

Environmental Health Sciences 

(NIEHS), National Institutes of Health 

(NIH), HHS.

ACTION: Meeting announcement and 

request for comment. 

SUMMARY: Pursuant to section 10(a) of 

the Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

SACATM on December 12, 2005. The 

meeting is scheduled from 8:30 a.m. to 

adjournment (~5 p.m.) and is open to 

the public with attendance limited only 

by the space available. SACATM 

advises the Interagency Coordinating 

Committee on the Validation of 

Alternative Methods (ICCVAM), the 

NTP Interagency Center for the 

Evaluation of Alternative Toxicological 

Methods (NICEATM), and the Director 

of the NIEHS regarding statutorily 

mandated duties of ICCVAM and 

activities of NICEATM. SACATM 

provides advice on priorities and 

activities related to the development, 

validation, scientific review, regulatory 

acceptance, implementation, and 

national and international 

harmonization of new, revised, and 

alternative toxicological test methods. 

Additional information about SACATM, 

including the charter, roster, and 

records of past meetings can be found at 

http://ntp.niehs.nih.gov/ see ‘‘Advisory 

Board & Committees.’’

DATES: The SACATM meeting will be 

held on December 12, 2005. All 

individuals who plan to attend are 

encouraged to register online at the NTP 

Web site by December 5, 2005, at http:/

/ntp.niehs.nih.gov/ select ‘‘Advisory 

Boards & Committees.’’ In order to 

facilitate planning for this meeting, 

persons wishing to make an oral 

presentation are asked to notify the 

Executive Secretary for SACTAM via 

online registration, phone, or e-mail by 

December 5, 2005, (see ADDRESSES

below). Written comments should also 

be received by December 5, 2005, to 

enable review by SACATM and NTP 

staff prior to the meeting.

ADDESSES: The SACATM meeting will 

be held at the Hilton Alexandria Old 

Town, 1767 King Street, Alexandria, VA 

22314. Public comments and other 

correspondence should be directed to 

Dr. Kristina Thayer, Executive Secretary 

for SACATM (NTP Liaison and 

Scientific Review Office, NIEHS, P.O. 

Box 12233, MD A3–01, Research 

Triangle Park, NC 27709; telephone: 

919–541–5021, fax: 919–541–0295; or email: thayer@niehs.nih.gov). Persons 

needing special assistance, such as sign 

language interpretation or other 

reasonable accommodation in order to 

attend, should contact 919–541–2475 

voice, 919–541–4644 TTY (text 

telephone), through the Federal TTY 

Relay System at 800–877–8339, or by email to niehsoeeo@niehs.nih.gov.

Requests should be made at least 7 days 

in advance of the event.

SUPPLEMENTARY INFORMATION: 

Preliminary Agenda and Availability of 

Meeting Materials 

A preliminary agenda is provided 

below. Additional background material 

will be posted on the NTP Web site as 

available at http://ntp.niehs.nih.gov/ see 

‘‘Advisory Board & Committees’’ or 

available upon request (see ADDRESSES

above). Following the meeting, 

summary minutes will be prepared and 

available at this Web site and upon 

request. 

Preliminary Agenda, Scientific 

Advisory Committee on Alternative 

Toxicological Methods, December 12, 

2005, Hilton Alexandria Old Town, 

1767 King Street, Alexandria, VA 22314. 

8:30 a.m. 

• Call to Order, Introductions, and 

Recognition of Retiring Members. 

• NICEATM and ICCVAM Update. 

• Overview of the May 2005 Ocular 

Toxicity Scientific Symposia. 

Æ Mechanisms of Chemically-Induced 

Ocular Injury and Recovery. 

Æ Reducing Pain and Distress in 

Ocular Safety Testing. 

• Performance Characteristics of the 

In Vivo Ocular Irritancy Test. 

Æ Public Comment. 

• ICCVAM Evaluation of In Vitro 

Methods to Identify Ocular Sever 

Irritants and Corrosives: Report from the 

Expert Panel (Presentation). 

Æ Bovine Corneal Opacity and 

Permeability (BCOP) Assay. 

Æ Isolated Chicken Eye (ICE) Assay. 

Æ Isolated Rabbit Eye (IRE) Assay. 

Æ Hen’s Egg Test—Chorion Allantoic 

Membrane (HET–CAM) Assay. 

Æ Reference Chemicals. 

12 p.m. 

LUNCH BREAK. 

1 p.m. 

• ICCVAM Evaluation of In Vitro 

Methods to Identify Ocular Severe 

Irritants and Corrosives: Report from the 

Expert Panel Continued. 

Æ Public Comment. 

• ICCVAM Nominations. 

Æ Public Comment. 

• ICCVAM–NICEATM–ECVAM 

Workshop on Validation Principles and 

Approaches for Toxicogenomic-based 

Method. 

Æ Public Comment. 

• ECVAM Update. 

• SACATM General Discussion. 

~5 p.m. 

ADJOURN. 

Request for Comments 

Public input at this meeting is invited 

and time is set aside for the presentation 

of public comments. Each organization 

is allowed one time slot per public 

comment period. At least 7 minutes will 

be allotted to each speaker, and if time 

permits, may be extended to 10 minutes. 

Registration for oral comments will also 

be available on-site, although time 

allowed for presentation by on-site 

registrants may be less than that for preregistered speakers and will be 

determined by the number of persons 

who register at the meeting. 

Persons registering to make oral 

comments are asked, if possible, to send 

a copy of their statement to the 

Executive Secretary for SACATM (see 

ADDRESSES above) by December 5, 2005, 

to enable review by SACATM and 

NIEHS/NTP staff prior to the meeting. 

Written statements can supplement and 

may expand the oral presentation. If 

registering on-site and reading from 

written text, please bring 40 copies of 

the statement for distribution and to 

supplement the record. Written 

comments received in response to this 

notice will be posted on the NTP Web 

site. Persons submitting written 

comments should include their name, 

affiliation, mailing address, phone, fax, 

e-mail, and sponsoring organization (if 

any) with the document. 

Background Information on SACATM 

The SACATM was established 

January 9, 2002, to fulfill section 3(d) of 

Public Law 106–545, the ICCVAM 

Authorization Act of 2000 [42 U.S.C. 

285l–3(d)] and is composed of scientists 

from the public and private sectors 

(Federal Register: March 13, 2002: Vol. 

67, No. 49, page 11358). The SACATM 

provides advice to the Director of the 

NIEHS, ICCVAM, and NICEATM 

regarding statutorily mandated duties of 

ICCVAM and activities of NICEATM. 

Additional information about SACATM, 

68070 Federal Register / Vol. 70, No. 216 / Wednesday, November 9, 2005 / Notices 

including the charter, roster, and 

records of past meetings can be found at 

http://ntp.niehs.nih.gov/ see ‘‘Advisory 

Board & Committees.’’ Information 

about NICEATM and ICCVAM activities 

can be found at the NICEATM/ICCVAM 

Web site (http://iccvam.niehs.nih.gov) 

or by contacting the Director of 

NICEATM, Dr. William Stokes 

(telephone: 919–541–2384, or E-mail: 

niceatm@niehs.nih.gov).

Dated: October 26, 2005. 

Samuel H. Wilson, 

Deputy Director, National Institute of 

Environmental Health Sciences.

[FR Doc. 05–22320 Filed 11–8–05; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Cleaning Mucus From 

Endotracheal Tubes

AGENCY: National Institutes of Health, 

Public Health Service, HHS.

ACTION: Notice.

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services, is 

contemplating the grant of an exclusive 

worldwide license to practice the 

invention embodied in E–061–2004/0, 

‘‘Mucus Shaving Apparatus for 

Endotracheal Tubes’’ (Patent 

Application Ser. No. 10/773,570 filed 

February 5, 2004), and E–061–2004/1, 

‘‘Mucus Shaving Apparatus for 

Endotracheal Tubes with Bacteriocidal 

Properties’’ (International Patent 

Application PCT/US2005/003395 filed 

February 5, 2005), to C.R. Bard, Inc., a 

New Jersey corporation having its 

headquarters in Murray Hill, New Jersey 

and a division, Bard Medical Division, 

having offices in Covington, GA. The 

United States of America is the assignee 

of the patent rights of the above 

invention. 

The contemplated exclusive license 

may be granted in the field of cleaning 

mucus deposits from endotracheal 

tubes.

DATES: Only written comments and/or 

applications for a license received by 

the NIH Office of Technology Transfer 

on or before January 9, 2006 will be 

considered.

ADDRESSES: Requests for a copy of the 

patent application, inquiries, comments 

and other materials relating to the 

contemplated license should be directed 

to: Michael A. Shmilovich, Esq., Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, MD 

20852–3804; Telephone: (301) 435–

5019; Facsimile: (301) 402–0220; E-mail: 

shmilovm@mail.nih.gov. A signed 

confidentiality nondisclosure agreement 

will be required to receive copies of the 

patent applications.

SUPPLEMENTARY INFORMATION: The patent 

applications intended for licensure 

disclose and/or cover the following: E–

061–2004/0, ‘‘Mucus Shaving Apparatus 

for Endotracheal Tubes,’’ and E–061–

2004/1, ‘‘Mucus Shaving Apparatus for 

Endotracheal Tubes with Bactericidal 

Properties.’’

This invention is an endotracheal 

tube cleaning apparatus for insertion 

into the inside of the endotracheal tube 

of a patient to shave away mucus 

deposits. This cleaning apparatus 

comprises a flexible central tube with an 

inflatable balloon at its distal end. 

Affixed to the inflatable balloon are one 

or more shaving rings, each having a 

squared leading edge to shave away 

mucus accumulations implicated in 

bacterial accumulation. In operation, the 

un-inflated cleaning apparatus is 

inserted into the endotracheal tube until 

its distal end is properly aligned with 

the distal end of the endotracheal tube. 

After proper alignment, the balloon is 

inflated by a suitable inflation device 

(e.g., a syringe) until the balloon’s 

shaving rings are pressed against the 

inside surface of the endotracheal tube. 

The cleaning apparatus is then pulled 

out of the endotracheal tube and in the 

process the balloon’s shaving rings 

shave off the mucus deposits from the 

inside of the endotracheal tube. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless, 

within sixty (60) days from the date of 

this published notice, NIH receives 

written evidence and argument that 

establishes that the grant of the license 

would not be consistent with the 

requirements of 35 U.S.C. 209 and 37 

CFR 404.7. 

Properly filed competing applications 

for a license filed in response to this 

notice will be treated as objections to 

the contemplated license. Comments 

and objections submitted in response to 

this notice will not be made available 

for public inspection, and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552.

Dated: October 31, 2005. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health.

[FR Doc. 05–22319 Filed 11–8–05; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

Open Meeting of the Federal 

Interagency Committee on Emergency 

Medical Services (FICEMS)

AGENCY: Federal Emergency 

Management Agency (FEMA), 

Department of Homeland Security.

ACTION: Notice of open meeting.

SUMMARY: FEMA announces the 

following open meeting. 

Name: Federal Interagency Committee 

on Emergency Medical Services 

(FICEMS). 

Date of Meeting: December 1, 2005. 

Place: 3rd Floor Conference Center, 

Potomac Room, Parklawn Building, 

5600 Fishers Lane Rockville, Maryland 

20857. 

Times: 10:30 a.m.—Main FICEMS 

Meeting; 1 p.m.—FICEMS Ambulance 

Safety Subcommittee. 

Proposed Agenda: Review and 

submission for approval of previous 

FICEMS Committee Meeting Minutes; 

Ambulance Safety Subcommittee and 

Counter-terrorism Subcommittee report; 

Action Items review; presentation of 

member agency reports; and reports of 

other interested parties.

SUPPLEMENTARY INFORMATION: This 

meeting will be open to the public with 

limited seating available on a first-come, 

first-served basis. See the Response and 

Security Procedures below. For those 

driving, parking is $7.00 per day. 

Response Procedures: Committee 

Members and members of the general 

public who plan to attend the meeting 

should contact Mr. Mike McKay, on or 

before Tuesday, November 29, 2005, via 

mail at NATEK Incorporated, 21355 

Ridgetop Circle, Suite 200, Dulles, 

Virginia 20166–8503, or by telephone at 

(703) 674–0190, or via facsimile at (703) 

674–0195, or via e-mail at 

mmckay@natekinc.com. This is 

necessary to be able to create and 

provide a current roster of visitors to 

HRSA Security per directives. 

Security Procedures: Increased 

security controls and surveillance are in 

effect at the Parklawn Building/HRSA 

facilities. All visitors must have a valid